Item 1.01
Entry into a Material Definitive Agreement.
On January 12, 2018 (the “
Closing Date
”), MSC Industrial Direct Co., Inc. (the “
Company
”) entered into two Note Purchase and Private Shelf Agreements.
Metropolitan Life Note Purchase Agreement
The Company entered into a Note Purchase and Private Shelf Agreement (the “
Met Life Note Purchase Agreement
”), by and between the Company and Metropolitan Life Insurance Company (“
MetLife
”) and/or one or more of its affiliates or related funds as purchasers thereunder. The Met Life Note Purchase Agreement provides for an uncommitted facility for the issuance and sale of up to an aggregate total of $250,000,000 of senior notes, at either fixed or floating rates. As of the Closing Date, the Company has not issued any notes under the Met Life Note Purchase Agreement.
Prudential Note Purchase Agreement
The Company entered into a Note Purchase and Private Shelf Agreement (the “
Prudential Note Purchase Agreement
”, by and between the Company and PGIM, Inc. (“
PGIM
”) and/or one or more of its affiliates or related funds as purchasers thereunder. The Prudential Note Purchase Agreement provides for an uncommitted facility for the issuance and sale of up to an aggregate total of $250,000,000 of senior notes, at a fixed rate.
The notes contemplated by each of the Met Life Note Purchase Agreement and the Prudential Note Purchase Agreement (the “
Senior Notes
”) would be senior unsecured obligations of the Company and rank equally with the Company’s borrowings under the revolving Credit Agreement, dated as of April 14, 2017 (the “
Credit Agreement
”), among the Company, the several banks and other financial institutions or entities from time to time parties thereto as lenders, and JPMorgan Chase Bank, N.A., as administrative agent; the Company’s 2.65% Series A notes, due July 28, 2023 (the “
2016 Series A Notes
”); and the Company’s 2.90% Series B notes, due July 28, 2026 (the “
2016 Series B Notes
” and together with the 2016 Series A Notes, the “
Existing Notes
”). The Existing Notes were issued pursuant to the Amended and Restated Note Purchase Agreement, dated as of April 14, 2017 (the “
Existing Note Purchase Agreement
”), among the Company and New York Life Insurance Company.
Senior Note Issuance
Also on the Closing Date, the Company completed the issuance and sale of $50 million aggregate principal amount of 3.04% Senior Notes due January 12, 2023 under the Prudential Note Purchase Agreement (the “
Prudential Senior Notes
”) in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended. The proceeds from the issuance and sale of the Prudential Senior Notes
have been
used to pay a portion of the revolving loans outstanding under the Credit Agreement. Following the issuance and sale of the Prudential Senior Notes, the aggregate availability under the Prudential Note Purchase Agreement is $200,000,000.
The Prudential Senior Notes mature on January 12, 2023 and bear interest at a rate of 3.04% per annum, payable semi-annually on January 12 and July 12 of each year, commencing on July 12, 2018. The Prudential Senior Notes are redeemable at any time subject to the payment of a make-whole amount equal to (i) the principal amount to be repaid together with the amount of interest that would have been due on such principal for the remaining term, discounted to present value at a discount rate equal to (x) the yield to maturity of a U.S. treasury security having a maturity equal to the remaining average life of the principal amount to be repaid plus (y) 50 basis points, minus (ii) the principal amount to be repaid.
Provisions of the Note Purchase Agreements
Each of the
Met Life Note Purchase Agreement and the Prudential Note Purchase Agreement
contains customary representations and warranties by the Company, certain of which include materiality, material adverse effect and knowledge qualifiers. Each of the
Met Life Note Purchase Agreement and the Prudential Note Purchase Agreement
also contains: (i) reporting covenants; (ii) affirmative covenants requiring the Company and its subsidiaries to comply with laws, maintain their properties and adequate insurance, pay taxes, maintain their corporate existence and add as additional guarantors any subsidiaries that become additional guarantors, borrowers, co-borrowers or otherwise become liable under the Credit Agreement, the Existing Note Purchase Agreement, the Met Life Note Purchase Agreement (in the case of the Prudential Note Purchase Agreement), the Prudential Note Purchase Agreement (in the case of the Met Life Note Purchase Agreement), and any other note purchase agreement, shelf facility or other similar institutional private placement financing providing for the issuance or sale of debt securities; and (iii) negative covenants restricting the ability of the Company and its restricted subsidiaries to incur additional indebtedness and liens, change their lines of business, make fundamental changes such as disposing of all or substantially all of their property, merging or consolidating with other companies, make investments, engage in transactions with affiliates, or enter into certain restrictive agreements. In addition, each of the
Met Life Note Purchase Agreement and the Prudential Note Purchase Agreement
contains two financial covenants: (i) the Company may not permit its consolidated leverage ratio to exceed 3:00 to 1:00 (or, at the election of the Company after its consummates a material acquisition, a four-quarter temporary increase to 3.50 to 1.00, during which the Company must pay an additional 0.50% interest on any notes outstanding during such period) as of the last day of any fiscal quarter and (ii) the Company may not permit its consolidated interest coverage ratio to be less than 3:00 to 1:00 as of the last day of any fiscal quarter.
Each of the
Met Life Note Purchase Agreement and the Prudential Note Purchase Agreement
contains customary events of default including: (i) non-payment of principal, interest and the make-whole amount, (ii) default in the performance of covenants (after certain cure periods for certain covenants), (iii) any representation or warranty proving to have been incorrect in any material respect, (iv) payment default and cross-acceleration to other material indebtedness, (v) customary bankruptcy and insolvency events, (vi) ERISA defaults, (vii) material judgments, and (viii) invalidity of or challenge to the enforceability of a subsidiary guaranty. Under each of the
Met Life Note Purchase Agreement and the Prudential Note Purchase Agreement
, if an event of default occurs and is continuing, the relevant required holders may accelerate the payment of the relevant issued notes together with accrued and unpaid interest and the make-whole amount. Acceleration will occur automatically if there is a bankruptcy or insolvency default.
Under each of the
Met Life Note Purchase Agreement and the Prudential Note Purchase Agreement
, in the event of a change of control of the Company, the Company will be required to offer to repurchase the issued notes at par value.
The foregoing descriptions of the Note Purchase Agreements are not complete and are qualified in their entirety by reference to the full terms and conditions of
the
Met Life Note Purchase Agreement and the Prudential Note Purchase Agreement, which are filed as Exhibits 10.1 and 10.2 to this Current Report on Form 8-K and incorporated herein by reference.